PDCD1 and myelodysplastic syndrome: Thus, in this study, we constructed a new risk stratification consisting of PDCD1, TIGIT, CD47, KIR3DL2 and the risk stratification based on the IPSS-R, which may provide more precise prognosis predictions for MDS.